3.6.4 Interventions 3.6.4.1 Probiotics Gut dysbiosis has been increasingly recognized as a contributor to cardiovascular disease (CVD) pathogenesis through mechanisms involving systemic inflammation and metabolic disruption, with probiotics and prebiotics emerging as promising strategies to restore microbiota balance and improve cardiovascular markers such as LDL cholesterol and high-sensitivity C-reactive protein (hs-CRP
Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read BPC-157 Peptide: Benefits, Uses, Side Effects, Dosage, and Research
New tools and approaches, e.g., 34 S labeling, exploitation of natural variation, and mathematical modeling will be necessary to obtain the comprehensive list of S-metabolite transporters and to understand the role they play in controlling sulfur metabolism and homeostasis in plants
There are numerous vitamin B12 pills on the market